The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Tribute Pharmaceuticals Canada Inc

Venture: TRX
Delayed quote

$1.59

Today's change0.00 0.00%
Updated August 28 2:32 PM EDT. Delayed by at least 15 minutes.
 

Tribute Pharmaceuticals Canada Inc

Venture: TRX
Delayed quote

$1.59

Today's change0.00 0.00%
Updated August 28 2:32 PM EDT. Delayed by at least 15 minutes.

Tribute Pharmaceuticals Canada Inc unchanged

Tribute Pharmaceuticals Canada Inc is unchanged today sitting at $1.59. Over the last five days, shares have gained 8.16% and 174.14% year to date. Shares have outperformed the S&P TSX by 211.26% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward78.33×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated August 28 2:32 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.29%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue6654
Total other revenue--------
Total revenue6654
Gross profit4432
Total cost of revenue2222
Total operating expense8655
Selling / general / administrative4323
Research & development--------
Depreciation / amortization1110
Interest expense (income), net operating--------
Unusual expense (income)1--0--
Other operating expenses, total--------
Operating income-201-1
Interest income (expense), net non-operating-1-1-10
Gain (loss) on sale of assets----0--
Other--------
Income before tax-9-5-13
Income after tax-9-5-13
Income tax, total0--00
Net income-9-5-13
Total adjustments to net income--------
Net income before extra. items-9-5-13
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-5-13
Inc. avail. to common incl. extra. items-9-5-13
Diluted net income-9-5-13
Dilution adjustment--------
Diluted weighted average shares109979588
Diluted EPS excluding extraordinary itemsvalue per share-0.08-0.05-0.010.03
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.07-0.05-0.010.03